Consensus Document SEPAR-AAMR-ALAT-ASONEUMOCITO-SMNCT on Assessment and Treatment for Consumers of New Tobacco and Nicotine Products.
СтатьяКлинические рекомендацииConsensus StatementНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rábade-Castedo Carlos, Cristóbal-Fernández Maribel, de Granda-Orive José Ignacio, Luhning Susana, Pacheco-Gallego Manuel Conrado, Regalado-Pineda Justino, Thirión-Romero Ireri, Blanquicett-Barrios Ledys Del Carmen, Medín María Inés, Buljubasich Daniel, Ramos-Pinedo Ángela, Gorordo-Unzueta Inmaculada, Frino-García Alejandro, Pastor-Esplá Esther, Cañón-Barroso Lourdes, Francisco-Corral Gloria, Sandoval-Contreras Raúl, Riesco-Miranda Juan Antonio, Borrajo María Cristina, Morán Alfredo, Hernández-Pérez María Andrea, Pérez-Padilla José Rogelio, Díaz-Santos Germán Augusto, Jiménez-Ruiz Carlos Andrés
Аннотация
The use of new tobacco and nicotine products (electronic nicotine delivery system, heated tobacco, and smoking water pipes) has increased in recent years worldwide. This has led to the emergence of a new smoker profile whose diagnostic and therapeutic approach is different from that of conventional tobacco smokers. The demand for help in quitting these new forms of smoking necessitates the development of guidelines or recommendations that are not currently available. Therefore, the Tobacco Control Group of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and in collaboration with Ibero American societies (AAMR, ALAT, ASONEUMOCITO, SNMCT) have produced a consensus document using the nominal focus group methodology, supported by a narrative review on the approach to smoking in users of electronic nicotine delivery systems (ENDS) and new forms of tobacco. The approach to diagnosing these types of users will be based on variables such as intensity, degree of nicotine dependence, self-efficacy, and motivation, using new scales or questionnaires. Psychological counseling will be based on psychoeducation, motivational interviewing, and cognitive-behavioral therapy. Nicotine replacement therapy, varenicline, cytisinicline, and burpropion are medications to consider for users of these devices.